Send feedback

CARD9 p.Val161Leu

c.481G>C · VCV4219148

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.254 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000424%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.254likely benign
REVEL0.118moderately benign-leaning
SaProtLLR -5.52tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.4GERP -3.4
Regional constrainto/e 1.03unconstrained · MANE · 7,773 bp · p 0.34 · regional, not allelic
Overall
CADD17.82PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000424% European (non-Finnish) · 5/1,179,264 alleles
Filtering AF 0.000124% ClinGen BA1/BS1 input FAF95, joint · FAF99 9e-05%
Overall 0.000548% 8/1,458,704 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.00481% 20,800
European (non-Finnish)grpmax 0.000424% 235,853

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CARD9
Protein
p.Val161Leu
Coding
c.481G>C
MANE Select
NM_052813
Type
single nucleotide variant
Location
chr9:136370987 (GRCh38)
Gene constraint
LOEUF 1.143 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 81.24 · 8 PDB
Residue 161
a UniProt-annotated variant site (in imd103; reduced cytokine production in response to c.albicans infection; impaired nf-kappa-b transcriptional activity); a UniProt-annotated variant site (in imd103; decreased production of cytokines in cd4(+) th17 cells)
Full CARD9 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/card9-p-val161leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown